Sodium channels caught in the act
Authors:
- 22 March 2019
- journal article
- editorial
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 363 (6433) , 1278-1279
Abstract
Voltage-gated sodium channels (VGSCs) are primarily responsible for initiation of action potentials in many excitable cells such as nerves and muscles. Mammals have nine isoforms of VGSCs, Nav1.1 to 1.9, with largely distinct expression patterns and physiological roles. Dysfunction of these channels leads to pathophysiologies ranging from epilepsies to chronic pain ([ 1 ][1]). These proteins are targets of potent toxins found in the venoms of animals such as spiders and scorpions ([ 2 ][2]), which modulate their activity by two broad mechanisms: They either clog the permeation pathway or bind at allosteric sites in the voltage-sensing domains (VSDs) of these proteins and modulate channel opening (gating modifier toxins, GMTs). VGSCs comprise four homologous domains, each of which contribute differently to channel gating, pharmacology, and ion selectivity. For instance, the fourth domain (DIV) contributes little to channel opening but is critical for fast inactivation ([ 3 ][3]). GMTs that bind to the VSDs of different domains exhibit different functional impacts on gating. This domain specificity of GMTs offers a valuable template to develop therapeutics to treat diseases arising from mutations causing gain-of-function or loss-of-function phenotypes. On pages 1302, 1309, and 1303 of this issue, Clairfeuille et al. ([ 4 ][4]), Pan et al. ([ 5 ][5]), and Shen et al. ([ 6 ][6]), respectively, provide detailed views of different VGSCs in their activated states, bound to pore-blocking toxins and GMTs, as well as a structure of a GMT-bound deactivated state of the channel. Additionally, Xu et al. ([ 7 ][7]) report structures of toxin-bound resting and activated states of an engineered sodium channel variant. Together, these studies provide unprecedented insights into the pharmacology and gating mechanisms of VGSCs. Pan et al. have elucidated the structure of the human brain-specific Nav1.2, in complex with the peptidic pore-blocking toxin, µ-conotoxin KIIIA. The toxin binds at the extracellular mouth of the ion permeation pathway. A specific lysine residue of the toxin occupies the putative sodium binding site in the selectivity filter of the channel. Such a binding mode probably ensures that the toxin is not knocked off by competing permeant ions and possibly accounts for the high blocking efficacy of these toxins. Interestingly, many of the residues mediating channel-toxin interactions are not conserved across Nav1.1 to 1.9, which likely accounts for the subtype specificity of the toxin ([ 8 ][8]). Clairfeuille et al. describe the structures of a chimeric channel containing the DIV VSD of Nav1.7 in the cockroach sodium channel in complex with the GMT AaH2 and in a toxin-free state. Comparison of the structures shows that the fourth transmembrane (S4) segment of DIV VSD undergoes a large conformational change upon toxin binding. The S4 segment harbors the positively charged residues (the gating charges), which sense the changes in the membrane electrical field and drive the conformational changes in the channel. A toxin-induced downward translocation of S4 is consistent with the role of AaH2 in inhibiting VSD activation. In the AaH2-bound channel structure, the authors observe salt-bridge interactions between gating charges at the intracellular end of the S4 segment and acidic residues in the carboxyl-terminal domain of the channel. The authors posit that these interactions may stabilize a ternary complex between the deactivated DIV VSD, carboxyl-terminal domain, and the cytoplasmic inactivation motif. Activation of the DIV VSD abolishes the putative salt-bridge interactions, disengaging the inactivation motif from the carboxyl-terminal domain, thereby driving the channel into an inactivated state. Such a mechanism can account for the distinct role of DIV in regulating channel inactivation ([ 3 ][3]). ![Figure][9] Conformational states of sodium channels Two domains (DII and DIV) of voltage-gated sodium channels are shown in chimeric form (top), in which the voltage sensor is replaced by a toxin-sensitive ortholog. The toxin bound wild-type voltage sensor (bottom) shows the activated conformation. GRAPHIC: C. BICKEL/ SCIENCE Xu et al. determined the structures of protoxin-II bound to a chimera of Nav1.7 DII VSD and the prokaryotic voltage-gated sodium channel from Arcobacter butzleri (NavAb) with the VSD in the activated and the resting state. The relative displacement of the S4 helix between the protoxin-II–bound resting and activated states was comparable to the AaH2-induced displacement ([ 4 ][4]). These authors propose that inhibitory GMTs such as protoxin-II bind to the resting VSD with high affinity and to the activated VSD with relatively lower affinity, which underlies their inhibitory effects. This mechanism is attractive from a pharmacological standpoint because it suggests that even during instances of high-frequency episodes, such as during epileptic seizures, the toxin may remain bound to the channel and exert its inhibitory effect to quell hyperexcitability. Whether such a hypothesis applies to all GMTs acting on naturally occurring VGSCs or specifically applies to the action of protoxin-II on the engineered channels remains to be tested. It is interesting, however, that Clairfeuille et al. were unable to capture the structure of AaH2 bound to the activated state of the DIV VSD. This might be either because of differences in the toxin-channel interactions or because the chimeric channel used by Xu et al. is homotetrameric, which might have made it easier to capture the different toxin-bound conformational states during cryo–electron microscopy (cryo-EM) reconstructions. Nav1.7 plays a critical role in pain sensation, and several genetic mutations in this isoform have been identified in diseases such as erythromelalgia, making it a crucial target for analgesics ([ 9 ][10]). Although the studies of Xu et al. prove that parts of DII VSD of Nav1.7 are...Keywords
This publication has 12 references indexed in Scilit:
- Structures of human Na v 1.7 channel in complex with auxiliary subunits and animal toxinsScience, 2019
- Molecular basis for pore blockade of human Na + channel Na v 1.2 by the μ-conotoxin KIIIAScience, 2019
- Structural basis of α-scorpion toxin action on Na v channelsScience, 2019
- Structural Basis of Nav1.7 Inhibition by a Gating-Modifier Spider ToxinCell, 2019
- Structural basis for activation of voltage sensor domains in an ion channel TPC1Proceedings of the National Academy of Sciences, 2018
- Na V 1.7 as a Pharmacogenomic Target for Pain: Moving Toward Precision MedicineTrends in Pharmacological Sciences, 2018
- Structure-based assessment of disease-related mutations in human voltage-gated sodium channelsProtein & Cell, 2017
- Domain IV voltage-sensor movement is both sufficient and rate limiting for fast inactivation in sodium channelsJournal of General Physiology, 2013
- Neurotoxins and Their Binding Areas on Voltage-Gated Sodium ChannelsFrontiers in Pharmacology, 2011
- Structure/Function Characterization of μ-Conotoxin KIIIA, an Analgesic, Nearly Irreversible Blocker of Mammalian Neuronal Sodium ChannelsJournal of Biological Chemistry, 2007